Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia
American Journal of Reproductive Immunology · 2023
DOI: 10.1111/aji.13680 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2023. Verfasst von Anna Maya Powell und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Premature Birth, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Maternal markers of intestinal immune activation may be used to predict preterm birth (PTB) in pregnant women living with HIV.
Methods
This study used de‐identified samples from the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) Protocol P1025 study. Singleton pregnancies with ≥3 ml plasma available and HIV viral load ≤400 copies/ml within 4 weeks of specimen collection were included. Frequency matching of PTB cases and term birth controls was performed on basis of maternal race, number of available plasma specimens, and timing of plasma sample collection in a 1:1 ratio. Plasma progesterone, 25‐hydroxy vitamin D, soluble CD14, intestinal fatty acid binding protein (I‐FABP), Lipopolysaccharide (LPS)‐binding protein, and inflammatory cytokines (IL‐1B, IFN‐gamma, IL‐6, TNF‐alpha) were measured. Generalized mixed linear regression modeling was used to examine the association between PTB and biomarkers, adjusting for covariates and confounders. Data analyses were performed using SAS 9.4 (Cary, NC).
Results
We included 104 PTB compared to 104 controls. Third trimester log2 IL‐1B was lower among PTB versus term birth controls by univariate analysis (–1.50 ± 2.26 vs. –.24 ± 2.69, p = .01) though this association was no longer significant by regression modeling. In an uncontrolled, exploratory sub‐analysis, subjects with prior PTB had increased odds of PTB with higher I‐FABP [aOR 2.72, 95% CI 1.18‐6.24] and lower IFN‐gamma [aOR .23, 95% CI .12‐.41] after adjustment for covariates and confounders.
Conclusions
Intestinal immune activation measured by soluble CD14 or intestinal fatty acid binding protein was not associated with preterm birth among pregnant women with low‐level HIV viremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- BEADCore, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Förderung
- NICHD NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
- National Institute of Mental Health
- National Institutes of Health
Zitieren
APA
Powell, A. M., Persaud, D., Anderson, J. R., Kacanek, D., Huo, Y., Psoter, K., Yanek, L. R., Ghanem, K., Burd, I., & International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team (2023). Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13680
Vancouver
Powell AM, Persaud D, Anderson JR, Kacanek D, Huo Y, Psoter K, et al. Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. 2023. doi:10.1111/aji.13680
BibTeX
@article{Powell2023,
author = {Powell, Anna Maya and Persaud, Deborah and Anderson, Jean Rene and Kacanek, Deborah and Huo, Yanling and Psoter, Kevin and Yanek, Lisa R and Ghanem, Khalil and Burd, Irina and International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team, International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team},
title = {Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia},
journal = {American Journal of Reproductive Immunology},
year = {2023},
doi = {10.1111/aji.13680}
}
EUVIMED